Sign in

CIK 0000882095 · Large accelerated filer

GILEAD SCIENCES, INC.

Sign in to watch
Ticker
GILD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
943047598
Phone
6505743000
Business address
333 LAKESIDE DR, FOSTER CITY, CA, 94404
Former names
GILEAD SCIENCES INC
  1. DEF 14A Proxy Proxy Statement
  2. 4 Planned sale Chief Comm & Corp Aff Officer sold 3,000 shares at $144.23 ($432,690)
  3. 4 Planned sale Chief Financial Officer sold 3,000 shares at $144.23 ($432,690)
  4. 144 Insider Sale of Securities
  5. 144 Insider Sale of Securities
  6. 4 Shares withheld for taxes Chief Financial Officer gave up 3,147 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Comm & Corp Aff Officer gave up 3,216 shares (to pay taxes)
  8. 4 Shares withheld for taxes EVP Gen Counsel, Legal & Comp gave up 606 shares (to pay taxes)
  9. 4 Derivatives Options or other derivatives
  10. 4 Shares withheld for taxes Chairman & CEO gave up 9,767 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Medical Officer gave up 1,063 shares (to pay taxes)
  12. SC TO-T Deal Tender Offer Statement
  13. 4 Grant or award Chief Financial Officer acquired 11,090 shares (grant or award)
  14. 4 Grant or award Chief Comm & Corp Aff Officer acquired 11,090 shares (grant or award)
  15. 4 Grant or award Chief Medical Officer acquired 8,530 shares (grant or award)
  16. 4 Grant or award EVP Gen Counsel, Legal & Comp acquired 470 shares (grant or award)
  17. 4 Planned sale Chairman & CEO sold 10,000 shares at an average $144.79 ($1,447,859)
  18. 144 Insider Sale of Securities
  19. 10-K Report Annual Report
  20. SC TO-C Deal Written Communication Relating to an Issuer

Page 6 of 160 · 3,186 filings